Iuliu Hatieganu, University of Medicine and Pharmacy
Cluj-Napoca, 400012, Romania
NCT Number: NCT06166849
The study is designed as a split-mouth randomised controlled study. This means within the mouth of one patient one tooth with an initial lesion is treated and coated with the Experimental Remineralization product whereas another comparable tooth with an initial lesion is left untreated. Patients are included upon meeting the inclusion criteria as defined for this clinical trial. In the test group, a remineralization of the incipient carious lesion is expected. The patients are recalled after 1 day (optional), 4 weeks, 4 months and finally after 1 year to evaluate the untreated and treated lesion.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Cluj-Napoca, 400012, Romania
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The two-step system, consisting of Component A and Component B, will be applied once on the white spot lesions
Time frame: Baseline to 1 Year
Analysis of incipient caries or demineralized enamel by using laser fluorescence technology.
Time frame: Baseline to 1 Year
Evaluation of the clinical status of the lesions:
0: Sound tooth surface: No evidence of caries after 5 sec air drying
Ivoclar Vivadent AG
Industry
Clinical Study of Tooth Enamel Remineralization Using DoReMin Product
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05738369
White Spot Lesion
Irbid, Jordan
View Trial DetailsNCT06131294
White Spot Lesion
Istanbul, Esenler, Turkey (Türkiye)
View Trial DetailsNCT06566833
White Spot Lesion
Alexandria, Professor, Egypt
View Trial DetailsNCT05738356
White Spot Lesion
Irbid, Jordan
View Trial Details